openPR Logo
Press release

Dengue Vaccine Market on Track for Strong Growth, Estimated to Grow at 12.3% CAGR Through 2029

10-06-2025 08:09 AM CET | Food & Beverage

Press release from: The Business Research Company

Dengue Vaccine

Dengue Vaccine

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Dengue Vaccine Market Through 2025?
Over recent years, the dengue vaccine market has seen exponential growth. The projections indicate that it is set to expand from a value of $0.41 billion in 2024 to $0.51 billion in 2025, showcasing a compound annual growth rate (CAGR) of 24.7%. This notable surge in the previous period can be linked to factors such as the rise in travel and urbanization, heightened demand for efficacious vaccines, an upturn in instances of foreign travel exposure, improvements in healthcare services, and an increase in large-scale vaccination initiatives.

What's the Projected Size of the Global Dengue Vaccine Market by 2029?
The market size for the dengue vaccine is forecasted to witness considerable expansion in the upcoming years. Expected to surge to a value of $1.14 billion by 2029, with a compound annual growth rate (CAGR) of 12.3%, the positive trajectory in the forecast period is linked to escalating dengue cases, intensified efforts from several institutions, expanding clinical trials, and a heightened focus on multi-strain and tetravalent vaccine formulations. Upcoming trends during the prediction period encompass growing requirements for preventative vaccines, breakthroughs in vaccine technology, manufacturing of combination vaccines, a surge in research and clinical trials for novel vaccine contenders, and an emphasis on enhancing vaccine effectiveness and safety standards.

View the full report here:
https://www.thebusinessresearchcompany.com/report/dengue-vaccine-global-market-report

Top Growth Drivers in the Dengue Vaccine Industry: What's Accelerating the Market?
The growth of the dengue vaccine market is anticipated to be fueled by the increasing instances of dengue fever. This viral infection, spread by Aedes aegypti mosquitoes, triggers high fever, headaches, joint pain, and rashes. Factors contributing to the rise in dengue fever cases include climate change, urbanization, inadequate mosquito control measures, and the evolution of the virus. The dengue vaccine functions by stimulating the immune system to recognize and fight the dengue virus, thereby reducing the severity of the infection and lowering the risk of severe complications. This eventually aids in decreasing the number of cases and related hospitalizations. For example, the World Health Organization, a Switzerland-based intergovernmental organization, reported in May 2024 that dengue cases in the American region had drastically increased to over 7 million in April 2024 from 4.6 million cases in 2023. It is due to these rising incidences of dengue fever that the dengue vaccine market is experiencing significant growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19026&type=smp

Which Emerging Trends Are Transforming the Dengue Vaccine Market in 2025?
Leading businesses in the dengue vaccine market are concentrating on the creation of more sophisticated vaccine recipes, including the dengue tetravalent vaccine, to provide comprehensive immunity against all four dengue virus strains in one single blend. This vaccine ensures immunity against all four dengue virus serotypes (DEN-1, DEN-2, DEN-3, and DEN-4), providing a complete defense against dengue fever. For example, in December 2022, Takeda Pharmaceutical Company, a pharmaceutical corporation based in Japan, was granted approval by the European Commission (EC) to use the QDENGA vaccine in those aged 4 years and older. This live attenuated vaccine is deployed in numerous dengue-prone regions to protect against dengue fever. It uses a weakened serotype two dengue virus as the genetic basis for the additional three serotypes. Administered in two doses of 0.5 mL each at 0 and 3 months, it is aimed at people aged four years and above. Phase 3 trial results showed Qdenga has a success rate of approximately 80.2% in warding off dengue, demonstrating greater efficacy in preventing hospitalizations. Its immunity duration is estimated to be around 4.5 years, outlasting many other vaccines.

What Are the Main Segments in the Dengue Vaccine Market?
The dengue vaccine market covered in this report is segmented -

1) By Type: Live Attenuated Vaccine, Chimeric Live Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccine, Nucleic Acid Based Vaccine
2) By Vaccine Phase: Phase I, Phase II, Phase III
3) By Treatment: Diuretic, Anti-Allergic, Blood Thinners, Other Treatments
4) By Route Of Administration: Oral, Parenteral, Other Routes Of Administration
5) By End-User: Hospitals, Clinics, Government Institutes, Non-Governmental Organizations, Other End-Users

Subsegments:
1) By Live Attenuated Vaccine: Single Strain, Multi-Strain
2) By Chimeric Live Attenuated Vaccine: Tetravalent Chimeric Vaccine, Monovalent Chimeric Vaccine
3) By Inactivated Vaccine: Whole Virus Inactivated Vaccine, Split Virus Vaccine
4) By Subunit Vaccine: Recombinant Protein Vaccine, Peptide-Based Vaccine
5) By Nucleic Acid Based Vaccine: DNA Vaccine, mRNA Vaccine

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19026&type=smp

Which Top Companies are Driving Growth in the Dengue Vaccine Market?
Major companies operating in the dengue vaccine market are Merck & Co. Inc., Sanofi Pasteur Limited, GlaxoSmithKline plc, Takeda Pharmaceutical Company, Sun Pharmaceutical Industries Ltd., Biological E. Limited, Saint Louis University, Indian Immunologicals Limited, Serum Institute of India Pvt. Ltd., Bavarian Nordic, Instituto Butantan, Bharat Biotech Ltd., Panacea Biotec Limited, SABIN Vaccine Institute, Medigen Vaccine Biologics Corporation, Emergex Vaccines Holding Ltd., BioNet-Asia Co. Ltd., Codagenix Inc., KM Biologics Co. Ltd., Chula Vaccine Research Center, Imutex Ltd.

Which Regions Will Dominate the Dengue Vaccine Market Through 2029?
Asia-Pacific was the largest region in the dengue vaccine market in 2024. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the dengue vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19026

This Report Supports:
1.Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2.Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3.Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4.Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dengue Vaccine Market on Track for Strong Growth, Estimated to Grow at 12.3% CAGR Through 2029 here

News-ID: 4208583 • Views:

More Releases from The Business Research Company

Organic Fertilizers Market: Major Trends Reshaping the Future of the Industry
Organic Fertilizers Market: Major Trends Reshaping the Future of the Industry
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. What Will the Organic Fertilizers Industry Market Size Be by 2025? The market for organic fertilizers has experienced significant augmentation in the past few years. The size of the market is projected to rise from $10.21 billion in 2024 to $11.11 billion in 2025, with a Compound Annual Growth
Flax Seeds Market Expansion Continues, with Forecast Valuation of $1.8 Billion by 2029
Flax Seeds Market Expansion Continues, with Forecast Valuation of $1.8 Billion b …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Flax Seeds Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for flax seeds has seen a swift expansion in the past few years. Its growth is projected to increase from $0.9 billion in 2024 to $1.03 billion in 2025, reflecting a 15.2% Compound
Agricultural Commodity Market Landscape to 2034: Key Forces Shaping the Next Decade of Growth
Agricultural Commodity Market Landscape to 2034: Key Forces Shaping the Next Dec …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. How Large Will the Agricultural Commodity Market Size By 2025? Over recent years, the stature of the agricultural commodity market has witnessed substantial growth. The market size, which stands at $5597.7 billion in 2024, is projected to scale up to $6068.24 billion in 2025, registering a compound annual growth
Processing Strawberry Market Poised to Hit $155.33 Billion by 2029 with Accelerating Growth Trends
Processing Strawberry Market Poised to Hit $155.33 Billion by 2029 with Accelera …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Processing Strawberry Market Size Growth Forecast: What to Expect by 2025? The size of the processing strawberry market has seen a rapid increase in recent years. It is projected to increase from $95.02 billion in 2024 to $105.52 billion in 2025, with a compound annual growth rate (CAGR) of

All 5 Releases


More Releases for Vaccine

Adult Vaccines Market By Type (Preventive Vaccine, Therapeutic Vaccine)
Global Adult Vaccines Market 2022 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market. Download Sample PDF at  https://www.theinsightpartners.com/sample/TIPRE00007244/?utm_source=OpenPR&utm_medium=10379 Key Players Analysis:  AstraZeneca  Bharat Biotech  Dynavax Technologies Corporation  GlaxoSmithKline  Johnson & Johnson  Merck and Co  Novartis  Pfizer  Sanofi Pasteur  Serum Institute of India The report covers key developments in the Adult Vaccines market as organic and inorganic growth strategies. Various companies are focusing
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Vaccine Market
Rise in the prevalence of infectious diseases, increase in immunization programs across the globe, and surge in R&D activities to develop new vaccine drive the growth of the global vaccine market. Global Vaccines Market was pegged at $32.46 billion in 2019, and is anticipated to hit $54.15 billion by 2027, registering a CAGR of 6.6% from 2020 to 2027. The report provides an in-depth analysis of the top investment pockets, top
US Flu Vaccine [Influenza Vaccine] Market Research Report 2020
DPI Research offers a latest published report on “Influenza Vaccines in the United States – Market Size, Trends, Opportunities and Growth Potential” delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key US flu vaccines market players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze
Measles Vaccine
Measles Vaccine Market describes its growth, size, share, Forecast and trends to 2025 Measles Vaccine Market Production and Demand Analysis 2019 to 2025 Measles Vaccine Market 2019 Manufacturing Analysis and Development Forecast 2025 Measles Vaccine Market 2019: Recent Study Including Growth Factors, Regional Drivers, Forecast 2025 Measles Vaccine Market to Insight By 2025: Top Key Vendors The global Measles Vaccine market is valued at million US$ in 2018 and will reach million US$ by the
Monovalent vaccine segment to accumulate maximum Paediatric Vaccine Market share
According to a new report published by Future Market Insights titled “Paediatric Vaccine Market: Global Industry Analysis & Opportunity Assessment, 2016 – 2026”, in terms of revenue, the global paediatric vaccine market is expected to increase at 12.2% CAGR during the forecast period 2016-2026. The global paediatric vaccine market is expected to reach US$ 27.97 Bn in 2016. Paediatric vaccine market is a billion dollar market accounting for a substantial proportion